CADL Past Earnings image   This CADL past earnings page last updated 5/16/2022
CADL Past Earnings
Data adjusted for CADL split history

PeriodPast Earnings DateAdj. EPS
Q1 20225/12/2022-0.300
Q4 20213/29/2022-0.230
Q3 202111/12/2021-0.260
Q2 20219/8/2021-0.310
CADL Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/12/20220.03M
Q4 20213/29/20220.03M
Q3 202111/12/20210.03M
Q2 20219/8/20210.03M
Quotes delayed 20 minutes

Email EnvelopeFree CADL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Candel Therapeutics (CADL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CAH Historical Earnings
CALA Historical Earnings
CAPR Historical Earnings
CARA Historical Earnings
CASI Historical Earnings
CATB Historical Earnings
CBAY Historical Earnings
CBIO Historical Earnings
CCCC Historical Earnings
CCEL Historical Earnings

CADL Past Earnings Q&A

What was the best and worst CADL past earnings results?
For Candel Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CADL past earnings result in our data set was -0.230/share posted in Q4 2021, while the lowest was in Q2 2021 when CADL posted -0.310/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when CADL reported 0.03M in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at 0.03M of revenue.

  Suggested answer: There are 4 CADL past earnings results in our data set.

On this page we presented the CADL past earnings date information for Candel Therapeutics. Reviewing that CADL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when CADL posted adjusted EPS of -0.230/share. Meanwhile the lowest CADL past earnings result was in Q2 2021, when CADL posted adjusted EPS of -0.310/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when CADL reported 0.03M in revenue, while the smallest revenue quarter was Q1 2022 when CADL reported 0.03M in revenue.

Any self directed investor doing their due diligence on CADL or any other given stock can benefit from researching all of the Candel Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Candel Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CADL. Thanks for visiting, and the next time you need to research CADL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: XLI Videos, BG Insider Buying, MEDW Videos.

 

CADL Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.